Novel melatonin-based treatments for major depression

The Lancet

Volumn 379, Issue 9812, 2012, Pages 215-

  Barbui, Corrado ^a   Cipriani, Andrea ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGOMELATINE; FLUOXETINE; PAROXETINE; MELATONIN;

CLINICAL TRIAL (TOPIC); DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; LETTER; LIVER DISEASE; MAJOR DEPRESSION; PRIORITY JOURNAL; NOTE;

DEPRESSIVE DISORDER, MAJOR; HUMANS; MELATONIN;

EID: 84856104385     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)60093-2     Document Type: Letter

References (3)

1. IB Hickie, NL Rogers Novel melatonin-based therapies: potential advances in the treatment of major depression Lancet 378 2011 621 631
2. SM Stahl, M Fava, MH Trivedi, A Caputo, A Shah, A Post Agomelatine in the treatment of major depressive disorder: an 8-week, multicenter, randomized, placebo-controlled trial J Clin Psychiatry 71 2010 616 626
3. European Medicines Agency CHMP assessment report for Valdoxan http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Public-assessment- report/human/000915/WC500046226.pdf (accessed Dec 16, 2011).